Original language | English (US) |
---|---|
Pages (from-to) | S28-S29 |
Journal | European Journal of Cancer |
Volume | 174 |
DOIs | |
State | Published - Oct 2022 |
Phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors
M. Macy, T. Cash, N. Pinto, J. G. Pressey, L. Szalontay, W. L. Furman, A. Bukowinski, J. H. Foster, G. K. Friedman, J. HaDuong, E. Fox, B. J. Weigel, J. Grevel, F. Huang, C. Phelps, B. H. Childs, J. Chung, S. Chaturvedi, A. Schulz, S. G. DuBois
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations